Lakeshore Biopharma (LSB) SEC Filings & 10K Form

$0.44

0.00 (0.00%)

(As of 09/6/2024 ET)

Compare

Stock Analysis Chart Competitors Earnings Financials SEC Filings Short Interest Trends

Recent Lakeshore Biopharma SEC Filings

Filing Types

Ownership Filings

Time Frame

Start Date

End Date

Export to Excel

Date	Filer	Form Type
09/04/2024 7:10 AM	LakeShore Biopharma Co., Ltd. (Filer) LakeShore Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
08/15/2024 7:40 AM	LakeShore Biopharma Co., Ltd. (Filer) LakeShore Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
08/15/2024 6:28 AM	LakeShore Biopharma Co., Ltd. (Filer) LakeShore Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)	Form 20-F Registration statement / Annual report / Transition report
07/31/2024 6:15 AM	LakeShore Biopharma Co., Ltd. (Filer) LakeShore Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)	Form NT 20-F
07/05/2024 6:15 AM	LakeShore Biopharma Co., Ltd. (Filer) LakeShore Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
06/18/2024 6:30 AM	LakeShore Biopharma Co., Ltd. (Filer) LakeShore Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
06/10/2024 6:01 AM	LakeShore Biopharma Co., Ltd. (Filer) LakeShore Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
Get the Latest News and Ratings for LSB and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Lakeshore Biopharma and its competitors with MarketBeat's FREE daily newsletter.
05/24/2024 6:45 AM	YS Biopharma Co., Ltd. (Filer) YS Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
05/21/2024 3:30 PM	YS Biopharma Co., Ltd. (Filer) YS Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
05/20/2024 3:16 PM	YS Biopharma Co., Ltd. (Filer) YS Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)	Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans
05/08/2024 7:32 AM	YS Biopharma Co., Ltd. (Filer) YS Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)	Form 424B3
04/29/2024 7:15 AM	YS Biopharma Co., Ltd. (Filer) YS Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
04/19/2024 7:03 AM	YS Biopharma Co., Ltd. (Filer) YS Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
04/18/2024 7:15 AM	YS Biopharma Co., Ltd. (Filer) YS Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
04/09/2024 7:20 AM	YS Biopharma Co., Ltd. (Filer) YS Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
04/03/2024 7:10 AM	YS Biopharma Co., Ltd. (Filer) YS Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
03/05/2024 7:06 AM	YS Biopharma Co., Ltd. (Filer) YS Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
02/23/2024 7:15 AM	YS Biopharma Co., Ltd. (Filer) YS Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
02/20/2024 5:17 AM	YS Biopharma Co., Ltd. (Filer) YS Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
02/16/2024 7:25 PM	YS Biopharma Co., Ltd. (Filer) YS Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
02/16/2024 3:14 PM	YS Biopharma Co., Ltd. (Subject) YS Biopharma Co., Ltd. (Subject) Lakeshore Biopharma (Subject) Zhang /MD Yi (Filed by)	Form SC 13G/A
02/14/2024 10:23 AM	Wong Fung Ching (Filed by) YS Biopharma Co., Ltd. (Subject) YS Biopharma Co., Ltd. (Subject) Lakeshore Biopharma (Subject)	Form SC 13D
02/14/2024 6:59 AM	YS Biopharma Co., Ltd. (Filer) YS Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
02/14/2024 7:01 AM	YS Biopharma Co., Ltd. (Filer) YS Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
02/14/2024 7:05 AM	YS Biopharma Co., Ltd. (Filer) YS Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
02/09/2024 6:10 AM	YS Biopharma Co., Ltd. (Filer) YS Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
01/25/2024 11:15 PM	YS Biopharma Co., Ltd. (Filer) YS Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)	Form EFFECT
01/26/2024 5:03 AM	YS Biopharma Co., Ltd. (Filer) YS Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
01/23/2024 3:18 PM	YS Biopharma Co., Ltd. (Filer) YS Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)	Form POS AM
01/22/2024 4:10 PM	YS Biopharma Co., Ltd. (Filer) YS Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
01/08/2024 6:10 AM	YS Biopharma Co., Ltd. (Filer) YS Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
12/20/2023 11:43 AM	YS Biopharma Co., Ltd. (Filer) YS Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
12/12/2023 5:37 AM	YS Biopharma Co., Ltd. (Filer) YS Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
10/31/2023 7:45 AM	YS Biopharma Co., Ltd. (Filer) YS Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
10/31/2023 7:46 AM	YS Biopharma Co., Ltd. (Filer) YS Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)	Form 424B3
10/26/2023 7:45 AM	YS Biopharma Co., Ltd. (Filer) YS Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
09/26/2023 8:10 AM	YS Biopharma Co., Ltd. (Filer) YS Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
09/26/2023 8:13 AM	YS Biopharma Co., Ltd. (Filer) YS Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)	Form 424B3
09/25/2023 5:12 AM	YS Biopharma Co., Ltd. (Filer) YS Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)	Form 424B3
09/25/2023 5:07 AM	YS Biopharma Co., Ltd. (Filer) YS Biopharma Co., Ltd. (Filer) Lakeshore Biopharma (Filer)	Form 424B3